His latest action confirms his intention to delist specific vaccines, making them less affordable.

Moderna stock soared early in the pandemic thanks to sales of its coronavirus vaccine. After soaring to success in the early ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

The current fear is that bird flu, H5N1, will become the next big pandemic. Only the mRNA platform is nimble enough to ...

Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...

A new COVID variant - NB 1.8.1 - is in New Jersey. Parents can take steps to protect their children from COVID this summer.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

The Trump administration is waging war against mRNA vaccines despite President Donald Trump having called them the “gold standard” when his admin rolled out the COVID shots […] ...

Novavax, Inc. (NVAX) on Wednesday said that its COVID-19-Influenza combination and stand-alone Influenza vaccine candidates ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Barclays Speaking the Science Call Series, on Monday, June 16 th at 10:00am ET A live webcast of this presentation will be available under "Events and Presentations" in the Investors section of the ...